Skip to content
GlucoBliss sale live — save up to $780 · Claim your discount
GlucoBliss
Claim Your Discount
Weight & Metabolism

Visceral Fat: Why Waist Size Predicts More Than Weight

Two people at the same weight can have very different metabolic risk, and this is usually why.

By Daniel Okafor, PhD Medically reviewed by Dr. Anita Raghunathan, MD, FACE Published 2026-07-14
Medically reviewed by Dr. Anita Raghunathan, MD, FACE · Last reviewed 2026-07-14. How we review.

Why is belly fat worse than other fat?

Visceral fat surrounds the internal organs and is metabolically active, releasing inflammatory cytokines and free fatty acids directly into the portal circulation to the liver. This interferes with insulin signalling and promotes hepatic fat accumulation. Subcutaneous fat under the skin is far less metabolically disruptive, which is why waist circumference predicts metabolic risk better than weight or BMI alone.

Two different tissues

Body fat is not one thing.

Subcutaneous fat sits under the skin, where most people can pinch it. It is relatively metabolically quiet and functions largely as intended — storage and insulation.

Visceral fat sits inside the abdominal cavity, surrounding the liver, pancreas and intestines. It is metabolically active tissue that behaves in some respects like an endocrine organ.

The distinction matters because they carry very different metabolic implications. Someone can have substantial subcutaneous fat and good metabolic markers, and someone else can be within a normal BMI with significant visceral fat and poor markers — a pattern sometimes described as metabolically obese normal weight.

What visceral fat does

  • Releases inflammatory cytokines including TNF-alpha and interleukin-6, which directly interfere with insulin receptor signalling.
  • Drains to the portal vein. This is the critical anatomical point. Free fatty acids released from visceral fat go straight to the liver in high concentration rather than being diluted in general circulation. The liver responds by increasing glucose output and by storing fat.
  • Reduces adiponectin. Adiponectin is an adipose hormone that improves insulin sensitivity, and its production falls as visceral fat rises.
  • Contributes to hepatic fat accumulation, which is itself strongly associated with insulin resistance.
  • Promotes a prothrombotic state, raising cardiovascular risk independently.

How to measure it

Imaging gives the accurate answer, but a tape measure is sufficient for practical purposes.

Waist circumference. Measure at the midpoint between the lowest rib and the top of the hip bone, at the end of a normal exhalation, without pulling the tape tight. Commonly cited thresholds sit around 94 cm for men and 80 cm for women for increased risk, with higher thresholds for substantially increased risk. These vary by ethnicity — lower thresholds are used for South Asian, Chinese and Japanese populations because risk appears at lower measurements.

Waist-to-height ratio. A simple and useful alternative: keep your waist below half your height. It requires no population-specific thresholds and predicts risk well.

What not to rely on: bathroom scale body fat percentages, which cannot distinguish visceral from subcutaneous and vary with hydration.

Support the system while you do the work

GlucoBliss is designed to sit alongside weight and activity changes, not replace them.

See Pricing

What reduces it

  1. Any sustained energy deficit. Visceral fat is preferentially mobilised early in weight loss, which is encouraging — the first few kilograms deliver disproportionate metabolic benefit.
  2. Aerobic exercise. Consistently associated with visceral fat reduction, including in studies where overall weight changed little.
  3. Resistance training. Builds muscle, which raises resting metabolic rate and glucose disposal capacity.
  4. Sleep. Short sleep is associated with visceral accumulation through the appetite and cortisol pathways.
  5. Reducing alcohol. Alcohol is metabolised in the liver and contributes to hepatic fat.
  6. Limiting added sugar, particularly liquid fructose, which is metabolised hepatically and associated with liver fat.
  7. Stress management, since cortisol promotes central fat distribution specifically.

What does not work

Targeted abdominal exercise. Crunches strengthen abdominal muscles and do not preferentially burn the fat above or behind them. Spot reduction is not a thing, and it has been tested.

Waist trainers and sweat belts. They compress and cause water loss. Nothing more.

Detox products. No.

Extreme short-term dieting. Loses muscle alongside fat and rebounds, frequently with a worse body composition than before.

Why the first five percent matters most

This is the most encouraging finding in this area.

Modest weight loss — around five to ten percent of body weight — produces disproportionately large improvements in insulin sensitivity, liver fat and metabolic markers, because early loss comes preferentially from visceral and hepatic stores.

For someone at 100 kg, that is five to ten kilograms. Not a transformation, and enough to move the markers that matter.

This reframes the goal usefully. The target is not a physique. It is the first five percent, held.

Sources & further reading

  1. NIDDK — Insulin resistance and body composition.
  2. American Diabetes Association — Obesity management standards of care.
  3. WHO — Waist circumference and waist-hip ratio guidance.
  4. Harvard T.H. Chan School of Public Health — Abdominal obesity and health.
DO

Daniel Okafor, PhD — Science Editor

PhD in biochemistry with a research background in insulin signalling and glucose transport. Writes the mechanism and ingredient-research content and is responsible for the standard that no study is cited for a conclusion it does not support.

PhD BiochemistryInsulin signalling researchPeer reviewer

Medically reviewed by Dr. Anita Raghunathan, MD, FACE. Read our editorial policy.

Medical disclaimer: This content is educational and is not medical advice. GlucoBliss is a dietary supplement and has not been evaluated by the FDA to diagnose, treat, cure or prevent any disease, including diabetes. It is not a substitute for prescribed medication or a diabetes care plan. Never stop or change a prescribed medication because you have started a supplement. If you take glucose-lowering medication, speak with your doctor or pharmacist before use — several ingredients here can have additive effects and increase hypoglycaemia risk.

Six named actives. Published interactions. 60-day guarantee.

See how GlucoBliss supports healthy blood sugar already in the normal range.

See Pricing & Order
Limited Stock

Support your metabolic health, one dropper a day.

Every GlucoBliss order is covered by a 60-day money-back guarantee. One-time payment, no subscription, no autoship.

Claim Your GlucoBliss Discount
Free US shipping on 3 and 6 bottle kits · Save up to $780 today
Save up to $78060-day guarantee
Order Now